While a number of National Institutions have come together to issue grant funding opportunities for investigating the effects of COVID-19, we’ve highlighted two recent “notice of intent to publish funding opportunities” that may be of interest below:

1. Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01-Clinical Trial Optional)

This initiative investigates the assessment of the strategies of community testing associated with the prevention of COVID-19 transmission and mitigation in health disparity populations as well as socioeconomic consequences during the pandemic. 

2. Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 – Clinical Trial Optional)

This initiative funding opportunity will investigate the impact of digital health interventions, telemedicine, and health information technology has on secondary health effects in health disparity populations due to COVID-19 Pandemic.

Since the demand for studies exploring the impact of COVID-19 has increased, Salimetrics has responded with tools and protocols to support current and future research study designs. Now, a more complete line of Salivary Immunoglobulin Assay Kits is available for researchers to qualify IgM and IgG in saliva samples when looking at infectious diseases. Coupling these tools with other available biomarkers, such as stress hormones and inflammatory cytokines, gives researchers an advantage when investigating health in vulnerable populations.

While new research opportunities emerge, Salimetrics is working to supply investigators with the tools they need, and we are here to assist your research. Ready to re-engage? Ask an Expert for help.